Addex Therapeutics Ltd announced that it has entered into a definitive agreement with Armistice Master Fund LTV, a healthcare-focused institutional investor, to sell 3,300,000 shares in the form of 550,000 American Depositary Shares at a gross purchase price of $1.70 per ADS, which is equivalent to CHF 0.27 per share.
July 22, 2022
· 5 min read